ABIONYX Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	118	41	41	48	68	24
Market Cap Growth	174.37%	-0.54%	-14.37%	-28.38%	178.53%	229.66%
Enterprise Value	119	39	44	49	63	17
Last Close Price	3.35	1.19	1.29	1.72	2.44	0.99
PS Ratio	27.36	9.07	8.94	9.23	100.22	-
PB Ratio	21.52	5.49	5.24	6.76	6.34	3.66
P/TBV Ratio	2233.17	20.02	16.83	28.22	12.95	3.69
EV/Sales Ratio	27.53	8.60	9.45	9.31	93.31	-
Debt / Equity Ratio	0.75	0.37	0.43	0.56	0.46	0.00
Net Debt / Equity Ratio	0.14	-0.06	-0.09	0.00	-0.28	-1.38
Net Debt / EBITDA Ratio	-0.16	0.11	0.22	0.01	0.51	3.10
Net Debt / FCF Ratio	-0.20	0.13	0.19	0.01	0.43	13.01
Asset Turnover	0.30	0.32	0.30	0.28	0.04	-
Inventory Turnover	17.39	17.16	21.86	28.49	-	-
Quick Ratio	1.30	1.49	1.68	1.39	1.86	2.78
Current Ratio	1.40	1.58	1.75	1.49	1.93	2.79
Return on Equity (ROE)	-61.53%	-56.76%	-46.62%	-47.14%	-67.28%	-28.37%
Return on Assets (ROA)	-20.47%	-19.67%	-13.91%	-13.64%	-23.16%	-18.07%
Return on Invested Capital (ROIC)	-74.81%	-62.69%	-47.57%	-55.39%	-228.97%	-
Return on Capital Employed (ROCE)	-50.90%	-45.40%	-31.30%	-38.30%	-39.50%	-44.40%
Earnings Yield	-3.89%	-10.62%	-8.48%	-8.68%	-8.61%	-7.76%
FCF Yield	-3.09%	-8.97%	-9.16%	-7.27%	-10.14%	-2.89%
Buyback Yield / Dilution	-11.34%	-14.80%	-4.95%	-12.41%	-5.92%	-11.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.